Clinical Trials

Chemotherapy Leaves Rapid, Drug‑Specific DNA Fingerprints in Relapsed Childhood Tumors

Platinum chemotherapy produces the largest share of therapy-linked mutations that can appear within months, suggesting mutation patterns could guide early detection of resistance pending clinical validation.